{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:28:50Z","timestamp":1766399330762},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,10]]},"DOI":"10.7759\/cureus.17869","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T11:06:03Z","timestamp":1631271963000},"source":"Crossref","is-referenced-by-count":2,"title":["A Retrospective Study of Hospitalizations in the USA: Proportion of Hospitalizations With Non-Alcoholic Fatty Liver Disease in Non-Obese Population"],"prefix":"10.7759","author":[{"given":"Olubunmi","family":"Oladunjoye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeolu O","family":"Oladunjoye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmi","family":"Dhital","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DilliRam","family":"Poudel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oreoluwa D","family":"Oladiran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibiyemi O","family":"Oke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Areoye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asad","family":"Jehangir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwaseun","family":"Shogbesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.171","article-title":"The global NAFLD epidemic","volume":"10","author":"Loomba R","year":"2013","unstructured":"Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013, 10:686-690. 10.1038\/nrgastro.2013.171","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.80","article-title":"Nonalcoholic fatty liver disease","volume":"1","author":"Brunt EM","year":"2015","unstructured":"Brunt EM, Wong VW, Nobili V, et al.. Nonalcoholic fatty liver disease. Nat Rev Dis Primers. 2015, 1:15080. 10.1038\/nrdp.2015.80","journal-title":"Nat Rev Dis Primers"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"Fan JG","year":"2017","unstructured":"Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol. 2017, 67:862-873. 10.1016\/j.jhep.2017.06.003","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.045","article-title":"Hepatic steatosis and cardiovascular disease outcomes: an analysis of the Framingham Heart Study","volume":"63","author":"Mellinger JL","year":"2015","unstructured":"Mellinger JL, Pencina KM, Massaro JM, et al.. Hepatic steatosis and cardiovascular disease outcomes: an analysis of the Framingham Heart Study. J Hepatol. 2015, 63:470-476. 10.1016\/j.jhep.2015.02.045","journal-title":"J Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.08.028","article-title":"Nonobese fatty liver disease","volume":"15","author":"Kim D","year":"2017","unstructured":"Kim D, Kim WR. Nonobese fatty liver disease. Clin Gastroenterol Hepatol. 2017, 15:474-485. 10.1016\/j.cgh.2016.08.028","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13069","article-title":"Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016","volume":"288","author":"Zou B","year":"2020","unstructured":"Zou B, Yeo YH, Nguyen VH, Cheung R, Ingelsson E, Nguyen MH. Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016. J Intern Med. 2020, 288:139-151. 10.1111\/joim.13069","journal-title":"J Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2337\/cd18-0026","article-title":"Patients with lean nonalcoholic fatty liver disease are metabolically abnormal and have a higher risk for mortality","volume":"37","author":"Golabi P","year":"2019","unstructured":"Golabi P, Paik J, Fukui N, Locklear CT, de Avilla L, Younossi ZM. Patients with lean nonalcoholic fatty liver disease are metabolically abnormal and have a higher risk for mortality. Clin Diabetes. 2019, 37:65-72. 10.2337\/cd18-0026","journal-title":"Clin Diabetes"},{"key":"ref8","unstructured":"HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality, Rockville, MD. (2011). Accessed. September 8, 2021: https:\/\/www.hcup-us.ahrq.gov\/tech_assist\/citations.jsp."},{"key":"ref9","unstructured":"HCUP National Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality, Rockville, MD. (2012). Accessed. September 8, 2021: https:\/\/www.hcup-us.ahrq.gov\/tech_assist\/citations.jsp."},{"key":"ref10","unstructured":"Joinpoint trend analysis software. (2019). Accessed. September 8, 2021: https:\/\/surveillance.cancer.gov\/joinpoint\/."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1519","article-title":"Prevalence and profile of nonalcoholic fatty liver disease in lean adults: systematic review and meta-analysis","volume":"4","author":"Young S","year":"2020","unstructured":"Young S, Tariq R, Provenza J, et al.. Prevalence and profile of nonalcoholic fatty liver disease in lean adults: systematic review and meta-analysis. Hepatol Commun. 2020, 4:953-972. 10.1002\/hep4.1519","journal-title":"Hepatol Commun"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.06.066","article-title":"Lean Americans with nonalcoholic fatty liver disease have lower rates of cirrhosis and comorbid diseases","volume":"19","author":"Weinberg EM","year":"2021","unstructured":"Weinberg EM, Trinh HN, Firpi RJ, et al.. Lean Americans with nonalcoholic fatty liver disease have lower rates of cirrhosis and comorbid diseases. Clin Gastroenterol Hepatol. 2021, 19:996-1008. 10.1016\/j.cgh.2020.06.066","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7120562","article-title":"Lean patients with non-alcoholic fatty liver disease have a severe histological phenotype similar to obese patients","volume":"7","author":"Denkmayr L","year":"2018","unstructured":"Denkmayr L, Feldman A, Stechemesser L, et al.. Lean patients with non-alcoholic fatty liver disease have a severe histological phenotype similar to obese patients. J Clin Med. 2018, 7:562. 10.3390\/jcm7120562","journal-title":"J Clin Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.04.045","article-title":"Liver and cardiovascular damage in patients with lean nonalcoholic fatty liver disease, and association with visceral obesity","volume":"15","author":"Fracanzani AL","year":"2017","unstructured":"Fracanzani AL, Petta S, Lombardi R, et al.. Liver and cardiovascular damage in patients with lean nonalcoholic fatty liver disease, and association with visceral obesity. Clin Gastroenterol Hepatol. 2017, 15:1604-1611. 10.1016\/j.cgh.2017.04.045","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1534","article-title":"Mortality of NAFLD according to the body composition and presence of metabolic abnormalities","volume":"4","author":"Golabi P","year":"2020","unstructured":"Golabi P, Paik JM, Arshad T, Younossi Y, Mishra A, Younossi ZM. Mortality of NAFLD according to the body composition and presence of metabolic abnormalities. Hepatol Commun. 2020, 4:1136-1148. 10.1002\/hep4.1534","journal-title":"Hepatol Commun"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2016.00068","article-title":"Non-alcoholic fatty liver disease in lean subjects: characteristics and implications","volume":"5","author":"Kumar R","year":"2017","unstructured":"Kumar R, Mohan S. Non-alcoholic fatty liver disease in lean subjects: characteristics and implications. J Clin Transl Hepatol. 2017, 5:216-223. 10.14218\/JCTH.2016.00068","journal-title":"J Clin Transl Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi Z","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, et al.. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018, 15:11-20. 10.1038\/nrgastro.2017.109","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.20524\/aog.2019.0402","article-title":"Prevalence, trends, outcomes, and disparities in hospitalizations for nonalcoholic fatty liver disease in the United States","volume":"32","author":"Adejumo AC","year":"2019","unstructured":"Adejumo AC, Samuel GO, Adegbala OM, et al.. Prevalence, trends, outcomes, and disparities in hospitalizations for nonalcoholic fatty liver disease in the United States. Ann Gastroenterol. 2019, 32:504-513. 10.20524\/aog.2019.0402","journal-title":"Ann Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.05.001","article-title":"Nonalcoholic fatty liver disease in Latinos","volume":"14","author":"Saab S","year":"2016","unstructured":"Saab S, Manne V, Nieto J, Schwimmer JB, Chalasani NP. Nonalcoholic fatty liver disease in Latinos. Clin Gastroenterol Hepatol. 2016, 14:5-12. 10.1016\/j.cgh.2015.05.001","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning JD","year":"2004","unstructured":"Browning JD, Szczepaniak LS, Dobbins R, et al.. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004, 40:1387-1395. 10.1002\/hep.20466","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.08.010","article-title":"Trends in the burden of nonalcoholic fatty liver disease in a United States cohort of veterans","volume":"14","author":"Kanwal F","year":"2016","unstructured":"Kanwal F, Kramer JR, Duan Z, Yu X, White D, El-Serag HB. Trends in the burden of nonalcoholic fatty liver disease in a United States cohort of veterans. Clin Gastroenterol Hepatol. 2016, 14:301-308. 10.1016\/j.cgh.2015.08.010","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/65322-a-retrospective-study-of-hospitalizations-in-the-usa-proportion-of-hospitalizations-with-non-alcoholic-fatty-liver-disease-in-non-obese-population","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:56Z","timestamp":1707507296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/65322-a-retrospective-study-of-hospitalizations-in-the-usa-proportion-of-hospitalizations-with-non-alcoholic-fatty-liver-disease-in-non-obese-population"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,10]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.17869","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,10]]}}}